TITLE

Malaria: Joint attack on malaria

AUTHOR(S)
Ellis, Clare
PUB. DATE
September 2004
SOURCE
Nature Reviews Microbiology;Sep2004, Vol. 2 Issue 9, p689
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the success of the study conducted by a group of international scientists that to develop a new antimalarial drug. The team, that is consists of researchers from universities and medical-related institutions worldwide, aims to identify a new synthetic peroxide antimalarial with oral potency, shorter treatment requirements, low toxicity, and is cheaper and easier to produce. The candidate drug will be taken under clinical trials on humans later this 2004.
ACCESSION #
22005168

 

Related Articles

  • News in brief . . .  // Reactions Weekly;6/18/2005, Issue 1056, p2 

    Presents updates on issues and events concerning medical researches in the U.S. as of June 2005. Reason for the temporary suspension of the clinical trial for the AV 1101 drug; Recommendations of Bristol-Myers Squibb for pregnant women taking the Sustiva drug; Postponement of the patient...

  • What Shall We Do About the Children? O'Donnell, Peter // Applied Clinical Trials;Jun2004, Vol. 13 Issue 6, p30 

    The European Union (EU) is trying to get its pediatric medicines proposal right. So the EU has been talking to everyone who will listen in a bid to get it right. Still wounded from the hostility to its clinical trials rules that came into effect in May, it is anxious to head off more criticism...

  • Patient study explores trial results question.  // European Pharmaceutical Executive;May/Jun2006, p14 

    The article reports that Taxotere as Adjuvant ChemoTherapy (TACT) has explored the question of if and how patients should be told of the results of clinical trials in which they participate. TACT's study revealed that posting results directly to patients' homes was preferred and that most of the...

  • Trials shock fuels public interest.  // European Pharmaceutical Executive;May/Jun2006, p16 

    The article reports on how the Parexel clinical trial elicited a surge of interested volunteers from the general public. Enter Trials is a web site through which patients can register to participate in clinical trials. It reported that after the Parexel incident, its server hits rose from...

  • Efficacy and safety of Ayurvedic medicines: Recommending equivalence trial design and proposing safety index. Sarmukaddam, Sanjeev; Chopra, Arvind; Tillu, Girish // International Journal of Ayurveda Research;Jul2010, Vol. 1 Issue 3, p175 

    Ayurvedic drugs have begun to be evaluated in controlled clinical trials. The trials, often placebo controlled, are usually designed to demonstrate superiority. Though the results have been usually reported as encouraging, statistical significance has been elusive. In this melee to show...

  • Hypothesis to acceptance. Butler, Mike // Pharmaceutical Technology Europe;Feb2009, Vol. 21 Issue 2, p42 

    The author reflects on the methods utilized in clinical trials. He emphasizes the need to filter suitable drug candidates before they enter phase I of a trial to reduce risk of failure. He argues that the use of a microdose approach in Phase 0 of clinical trials can increase the reliability of...

  • Integration of Translational Research in the European Organization for Research and Treatment of Cancer Research (EORTC) Clinical Trial Cooperative Group Mechanisms. Lehmann, Frederic; Lacombe, Denis; Therasse, Patrick; Eggermont, Alexander M. M. // Journal of Translational Medicine;2003, Vol. 1, p2 

    The landscape for cancer research is profoundly different today from that only one decade ago. Basic science is moving rapidly and biotechnological revolutions in molecular targeting and immunology have completely modified the opportunities and concepts for cancer treatment. In contrast to the...

  • Participants in research. Sackett, David L. // BMJ: British Medical Journal (International Edition);5/21/2005, Vol. 330 Issue 7501, p1164 

    Presents an editorial on the basis of perceptions surrounding human clinical trials. How a majority of the public consider trial participants to be guinea pigs, and consider altruistic goals more likely to be achieved than getting the best possible treatment; Impact of the abuse of trial...

  • Development of a Sexual Function Questionnaire for Clinical Trials of Female Sexual Dysfunction. Quirk, Frances H.; Heiman, Julia R.; Rosen, Raymond C.; Laan, Ellen; Smith, Michael D.; Boolell, Mitra // Journal of Women's Health & Gender-Based Medicine;Apr2002, Vol. 11 Issue 3, p277 

    Objective: To better evaluate efficacy in clinical trials of drugs as potential treatments for female sexual dysfunctions (FSD), a brief, multidimensional measure of female sexual function was developed. Methods: Data from semistructured interviews with 82 women with or without FSD, aged 19-65...

  • pharma Industry Mulls 'Phase O' Clinical Trials. Scott, Alex // Chemical Week;10/4/2006, Vol. 168 Issue 33, p47 

    The article reports on the proposal for a phase 0 clinical trials of drugs. The phase 0 clinical trials have been proposed to reduce the high rate of failure of drugs in early stage clinical trials. Using such trials, micro-dose quantities of drugs would be tested on humans prior to phase I...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics